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Womenwithahistoryofgestationaldiabetesmellitus(GDM)areatincreasedriskfordiabetesmellitusbutpostpartumfollowupis
problematic for frequent nonattendance. Our aim was to increase coverage of postpartum oral glucose tolerance tests (ppOGTTs)
and examine associated factors. This was a prospective observational study of altogether 266 high-risk women for GDM from
2005 to 2008 in four Finnish municipalities. The groups were as follows: women (n = 54) who had previously participated in
early pregnancy lifestyle intervention study and high-risk women (n = 102) from the same municipalities studied within one-
year after delivery. Furthermore, in two neighboring municipalities nurses were reminded to perform a ppOGTT on high-risk
women (n = 110). The primary outcome was the prevalence of ppOGTT performed and associated factors. Overall the ppOGTT
was performed in 35.7% of women. Only 14.7% of women returned for testing to health care centers, 30.9% after a reminder in
municipalities, and 82.5% to the central hospital, respectively. The most important explaining factor was a special call or reminder
from the central hospital (OR 13.4 (4.6–38.1), P<0.001). Thus, additional reminders improved communication between primary
care and secondary care and more attention to postpartum oral glucose testing in primary care are of great importance.
1.Introduction
Gestational diabetes mellitus (GDM) implies a substantial
risk of later diabetes. Pregnancy seems to identify women
who are at risk of developing diabetes later in life. In our
study the prevalence of GDM in South Ostrobothnia was
13.0% [1]. About 10% of Finnish women with GDM will
develop diabetes over the next 6 years; nearly half of them
develop type 1 diabetes and the other half type 2 diabetes
[2].Inthemeta-analysisof675,455womenwith10,859cases
of type 2 diabetes Bellamy found that women who have had
gestational diabetes have at least a sevenfold increased risk of
developing type 2 diabetes mellitus in the future compared
with those who have had a normoglycaemic pregnancy. The
strength of the association between gestational diabetes and
type 2 diabetes and the knowledge that many of the risk
factors (family history of diabetes, raised body-mass index,
increased age, and Asian and black origin) are the same,
suggest that the two disorders might have an overlapping
cause [3].
Recommendations from the International Workshop
Conference of GDM suggest screening at 6 weeks post-
partum using the 75gram, 2 hour oral glucose tolerance
test (OGTT), which should then be repeated at one-year2 International Journal of Endocrinology
postpartum and then at least every 3 years thereafter [4]. The
postpartum period allows for the identiﬁcation of women at
highriskfordiabetesandprovidesanimportantopportunity
for intervention. Type 2 diabetes has been prevented or
delayed by lifestyle intervention not only in randomized
controlled studies [5], but also in the primary health care
setting [6].
Despite the elevated risk for diabetes and recommenda-
tions for close followup, the opportunities for postpartum
screening and intervention are missed. The variation of
screening rate is from 14% in usual care to 60% in a ran-
domized controltrial [7]. In a retrospective study a reminder
system of automated orders to physicians and telephone and
e-mail reminder messages to patients improves the coverage
of tested women 50% [8].
GDM strongly predisposes to type 2 diabetes. GDM and
type 2 diabetes also share many of the same risk factors,
suggesting that the two disorders have an overlapping path-
ogenesis [3]. Excessive gestational weight gain is a risk,
factor for short-term postpartum weight retention and thus
overweight in women. In a meta-analysis of >65,000 women
Nehring showed that women with a gestational weight gain
above recommendations retained 3kg more weight 3 years
postpartum than did those who gained weight within the
recommendations [9]. Therefore, women at a high risk for
GDM are a high-risk group for diabetes, especially if they
have postpartum weight retention.
Our aim in this study was to explore the optimal strat-
egies to increase the amount of postpartum oral glucose
tolerance test (ppOGTT). The primary outcome was the
prevalence of women at high risk for GDM who underwent
an OGTT in the postpartum period in four rural munic-
ipalities. In two municipalities we had our previous early
pregnancy intervention study group women for preventing
GDM [1] and other high-risk women for GDM with
usual care, and in two neighboring municipalities high-risk
women who received a special telephone call for postpartum
glucose testing.
2. Methods
This study was a prospective observational multicenter study
of postpartum glucose screening in 266 women at high risk
for GDM in South Ostrobothnia, Finland. The risk of GDM
wasestimatedduringindexpregnancyfromApr2005toMay
2006. We analyzed data from Apr 2005 to Jan 2008 from
Sein¨ ajoki Central Hospital and four rural municipalities
Kauhajoki, Lapua, Jalasj¨ arvi, and Kurikka.
A database contained clinical, glycemic, and delivery
data of all women from four municipalities in the study
period. The inclusion criteria for this study were at least
one of the follows: (1) BMI >25kg/m2, (2) birth of child
>4.5kg, (3) age over 40 years, (4) family history of diabetes
and (5) glucosuria. The risk factors for GDM were reasked
in connection with the ppOGTT at the central hospital
and in the neighboring municipalities. In the usual care
municipalities the information of risk factors was extracted
from the self reported questionnaire in the beginning of
index pregnancy.
We included also our previous early pregnancy lifestyle
intervention study group to the current examination. The
protocol was approved by the ethics committee of South
Ostrobothnia Hospital District in Sein¨ ajoki, Finland. It was
in accordance with Helsinki Declaration. All women partici-
pating in ppOGTT gave written informed consent.
2.1. Diabetes Care during Pregnancy. According to guidelines
in Finland at the time of study, GDM testing was focused
on women with risk factors. Diagnosis of glucose intolerance
was established by 2-h 75-g OGTT performed between 24
and 28 weeks of gestation. In women with a high risk for
diabetes, testing was done in early pregnancy. OGTT testing
wasalsooﬀeredifwomenhadpolyhydramnion,macrosomia
or glucosuria later during pregnancy [10]. The GDM
criteria were modiﬁed from the World Health Organization
as a fasting plasma glucose ≥5.6mmol/L or 2h plasma
glucose ≥7.8mmol/L [1]. From 1998 onward, the WHO
classiﬁed any glucose levels above normal as indicative of
gestational diabetes [11].
The health care nurses gave women counseling about
healthy lifestyle in the beginning of pregnancy. The dietary
and exercise advice were provided both verbally and writing.
Women were advised to stop alcohol intake and smoking.
The nurse in the health care centers had on average 13
appointments with the women during pregnancy.
In the study group a clinical nutritionist gave dietary
advice tailored to each subject individually six times and a
physiotherapist gave exercise advice six times. In the control
group the women were given general information on diet
and physical activity in a single session to decrease the risk
of GDM during pregnancy group [1].
AfteradiagnosisofGDMwomenweregiveninstructions
and advised to perform blood glucose monitoring. Insulin
therapy was initiated when fasting capillary plasma glucose
exceeded 5.8mmol/L and postprandial capillary plasma
glucose was >8.5mmol/L in the study period.
All the women were followed in maternal health care
in municipalities and all the women gave birth at the
Central Hospital of Sein¨ ajoki. During pregnancy the women
were seen at the central hospital only if fasting capillary
plasma glucose exceeded 5.8mmol/L or postprandial cap-
illary plasma glucose exceeded 8.5mmol/L or in the case
of macrosomia, polyhydramnion, lack of compliance, BMI
>30kg/m2, or some complicating illness.
2.2. Postpartum Testing. Women with GDM requiring in-
sulin were asked to continue glucose testing at home after
discharge. The women with a diagnosis of GDM were
oﬀered an OGTT after one year after delivery based on local
instructions.
The high-risk women who underwent a lifestyle inter-
vention during pregnancy were oﬀered an OGTT at the
central hospital irrespective of whether they developed
GDM. We generated a list of women at high risk for GDM
in two neighboring municipalities, took it to the health care
nurses and advised them to call the women by telephone for
glucose testing in the primary care.International Journal of Endocrinology 3
Table 1: Characteristics of the women at high risk for gestational diabetes mellitus during the index pregnancy.
Characteristics No postpartum glucose screening (n = 171) Postpartum glucose screening (n = 95) P1
Age (years), mean ± SD 30.1 ±5.73 0 .2 ±5.7 0.968
<25 (%) 19.3 (33/171) 18.9 (18/95)
25–35 (%) 63.2 (108/171) 61.1 (58/95)
≥36 (%) 17.5 (30/171) 20.0 (19/95)
Educational status 0.044
Higher education (%) 8.8 (15/171) 26.3 (25/95)
Other education (%) 91.2 (156/171) 73.7 (70/95)
Parity 0.001
Nulliparous (%) 25.1 (43/171) 45.3 (44/95)
Multiparous (%) 74.9 (128/171) 53.7 (51/95)
Body mass index (kg/m2), mean ± SD 28.2 ±5.42 6 .7 ±4.7 0.024
≤25.0 (%) 26.3 (45/171) 38.9 (37/95)
25.1–30.0 (%) 45.0 (77/171) 45.3 (43/95)
30.1–35.0 (%) 19.9 (35/171) 9.5 (9/95)
>35.0 (%) 8.2 (14/171) 6.3 (6/95)
Weight gain (kg), mean ± SD 11.5 ±6.51 2 .0 ±5.8 0.453
≤11.5 (%) 50.9 (87/171) 46.3 (44/95)
11.6–16.0 (%) 26.9 (47/171) 28.4 (27/95)
>16.0 (%) 21.1 (37/171) 24.2 (23/95)
GDM diagnosed (%) 19.9 (34/171) 24.2 (23/95) 0.385
Insulin therapy during pregnancy (%) 6.4 (11/171) 10.5 (10/95) 0.235
Blood sample of newborn for glucose (%) 36.3 (62/171) 48.4 (46/95) 0.049
Risk factors for GDM
BMI >25 (kg/m2) (%) 78.9 (135/171) 67.4 (64/95) 0.037
Previous birth of child >4.5kg (%) 5.3 (9/171) 1.1 (1/95) 0.102
Age >40 years (%) 3.5 (6/171) 3.2 (3/95) 1.000
Previous history of GDM (%) 18.1 (31/171) 14.7 (14/95) 0.480
Family history of diabetes (%) 18.1 (31/171) 52.6 (50/95) <0.001
Special call for OGTT (%) 49.1 (84/171) 83.2 (79/95) <0.001
1P values (two sided): χ2 test or Mann-Whitney U-test.
A 75g 2h oral glucose tolerance test after overnight
fasting for 12 hour was performed one year post partum.
Diabetes was diagnosed by either fasting venous plasma glu-
cose ≥7.0mmol/L or 2h value ≥11.1mmol/L, impaired fast-
ing glucose (IFG) tolerance by fasting glucose ≥6.1mmol/L
and impaired glucose tolerance (IGT) by 2-h glucose
≥7.8mmol/L and <11.1mmol/L.
2.3.DataCollectionandStatisticalAnalysis. Antenatalmater-
nal clinical, glycemic, delivery, neonatal, and ppOGTT data
were derived from the database of the central hospital and
the health care centers. Variables considered as potentially
predictive for a participation in the ppOGTT were analyzed
with the statistical package SPSS 19.0 (SPSS, Chicago, IL,
USA). Data are presented as numbers and proportion for
categorical variables or as means ± SD for continuous
variables, respectively. A χ2 test or two-sided Mann-Whitney
U-test was used to test for diﬀerences between women
who participated in the ppOGTT and those who did not.
Diﬀerences with P<0.05 were regarded as statistically sig-
nificant. A multivariable logistic regression model was used
to evaluate the association between participation in the pp-
OGTT and demographic factors, anthropometric and clini-
cal risk factors and special call for ppOGTT. Results for each
risk factor are presented as odds ratios (ORs) with 95% CI.
3. Results
The baseline characteristics of the 266 women at high risk
for GDM are seen in Table 1. The women in the lifestyle
intervention study group (n = 54) were thinner (P = 0.040),
they were more often nulliparous (P = 0.001) and more
frequently had a family history of diabetes (P = 0.005) than
the other women at a high risk for GDM (n = 212). During
pregnancy GDM was diagnosed in fewer women (P = 0.005)
in the lifestyle intervention group (P = 0.010) than in the
other high-risk women (data not shown). Otherwise there
were no diﬀerences on tested baseline variables between the
lifestyle intervention group and other risk women for GDM
in four municipalities.
Women who underwent ppOGTT were more likely to
have received a telephone call from the central hospital to4 International Journal of Endocrinology
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Figure 1:Theﬂowchartofpostprandialglucosescreeninginwomenathighriskforgestationaldiabetesmellitus.1GDM:gestationaldiabetes
mellitus, 2BMI: body mass index, 3OG TT :o ra lgl u c o s et o l e ra n c et e s t ,4DM: diabetes mellitus, 5IFG: impaired fasting glucose, 6IGT: impaired
glucose tolerance.
remind about the OGTT than women who did not undergo
testing (83.2% (79/95) and 49.1% (84/171), respectively,
P<0.001). The women in the lifestyle intervention study
group returned for testing signiﬁcantly more often than the
other women at high risk for GDM, adjusted OR 2.5 (5.4–
29.5), P<0.001. The overall return rate for postpartum
testing in women was 35.7% (95/266). In the usual care
in the two municipalities in which no reminder call was
made the return rate was lowest 14.5% (15/102), 30.9%
(34/110) for those receiving the reminder call and in the
lifestyle intervention study group 85.2% (46/54) (Figure 1).
Allofthewomenwhoparticipatedinpostpartumtestingalso
had OGTT during pregnancy. In the lifestyle intervention
study group, 6 women were pregnant again, one had moved
away, and one was not willing to undergo testing. In the
reminder group 7 women were pregnant, and 68 women
refused testing for professional or child care reasons or most
because of unknown problems. In the usual care group the
reasons could not be assessed.
We tested age, educational status, parity, BMI, weight
gain during pregnancy, GDM diagnosed during pregnancy,
blood sample of newborn for glucose and risk factors for
GDM (BMI >25kg/m2, previous birth of child >4.5kg,
age >40 years, previous history of GDM and family history
of diabetes), and special call for ppOGTT. In univariable
analysisunadjustednulliparouswomen,womenwithnormal
weightandhighereducationreturnedmoreoftenforglucose
testing (Table 1).
The most important explanatory factorwas the reminder
telephone call for testing either at the central hospital or
reminding from the central hospital to the care providers in
the health care centers (adjusted OR 13.4 (4.6–38.1), P<
0.001). Another statistically signiﬁcant risk factor was family
history of diabetes, (adjusted OR 5.1 (2.1–12.2), P<0.001)
(Table 2).
Fourteen women (8.2%) had abnormal glucose toler-
ance: 3 had DM-, 4 had IGT- and 7 had IFG. Two women
out of 4 with IGT diagnosis and one woman out of 7 with
IFG-diagnosis had normal glucose tolerance during preg-
nancy. One woman was obese, BMI 40kg/m2 and she had
2kg of weight retention postpartum, the other had 8.5kg of
weight retention and the third 6kg.
4. Discussion
GDM is a signiﬁcant risk factor for the development of
diabetes. Early identiﬁcation of women at high risk for
diabetes is critical to prevent or delay onset of diabetes.
However, in the real world the opportunities for postpartum
screening and intervention are frequently missed. In the
present study the inclusion criteria were BMI >25kg/m2,
birth of child >4.5kg, age over 40 years, family history of
diabetes and glucosuria. In the usual care in the health
care centers, the testing rate was only 14.5%. The return
rate was doubled (30.9%) in municipalities in which health
professionals from the central hospital reminded the nurses
in health care centers to call the high-risk women for
glucose testing. The return rate for postpartum testing of
women at high risk for GDM was highest (85.2%) in those
who participated in the lifestyle intervention study group.
Thus a simple reminder from the central hospital was the
most important factor explaining better compliance with
ppOGTT. To our knowledge there are no earlier reports
of postpartum testing women with risk factors for GDM
without GDM diagnosis.
The overall return rate for postpartum testing was 35.7%
(14.5%, the usual care;30.9%, afterthe reminder call;82.5%,
the study group) in the current study. The frequency of
follow-upwithanOGTTwas33.7%inaretrospectivecohort
study of women with previous GDM (n = 745) in New York
[12]. The overall return rate was 51.1% (79.6%, Kiel; 65.0%,
Bonn; 23.4%, Berlin) in a German prospective multicenter
study of 605 women with GDM [13]. In the Canadian study
the postpartum reminding system doubled screening rate
from 14% to 28% in the usual care [7]. This result is in
accordance with our study. All the Canadian women hadInternational Journal of Endocrinology 5
Table 2: Multivariable logistic regression model predicting post-
partumglucosescreening amongwomen athighriskforgestational
diabetes mellitus.
Odds ratio (95% CI)1 P
Age (years)
<25 1.00
25–35 0.73 (0.25–2.15) 0.571
>35 0.75 (0.19–2.98) 0.684
Educational status
Other education 1.00
Higher education 0.65 (0.25–1.73) 0.393
Parity
Nulliparous 1.00
Multiparous 0.51 (0.20–1.27) 0.149
Body mass index (kg/m2)
≤25.0 1.00
25.1–30.0 1.07 (0.18–6.36) 0.941
30.1–35.0 1.79 (0.25–12.86) 0.564
>35.0 1.67 (0.19–14.83) 0.646
Weight gain during pregnancy
≤11.5 1.00
11.6–16.0 0.71 (0.27–1.89) 0.491
>16.1 0.67 (0.23–1.92) 0.454
GDM diagnosed during index
pregnancy 2.23 (0.54–9.26) 0.269
Insulin therapy during index
pregnancy 1.31 (0.19–9.12) 0.782
Blood sample of newborn for
glucose 1.30 (0.57–2.97) 0.536
Risk factors for GDM
BMI >25 (kg/m2) 0.99 (0.29–3.36) 0.989
Previous birth of child >4.5kg 0.21 (0.01–3.09) 0.256
Age >40 years 0.95 (0.13–7.06) 0.961
Previous history of GDM 1.63 (0.48–5.52) 0.435
Family history of diabetes 5.09 (2.13–12.12) <0.001
Special call for OGTT 13.4 (4.64–38.1) <0.001
1Adjusted odds ratios (ORs), and their 95% conﬁdence intervals (CIs) and
P values.
GDM, whereas in our study 21.4% (57/266) had GDM, and
the rest were at high risk for GDM. However, 42% (11/26)
of those women who had GDM returned for glucose testing
in usual care. All (4/4) of the women with GDM who had
undergone in the lifestyle intervention and 33% (9/27) of the
women with GDM who were given a reminder telephone call
took a postpartum OGTT. It is worth noting that 2 women
with IGT and one woman with IFG had normal glucose
toleranceduringpregnancy.Onewomanwasmorbidlyobese
and the rest had excessive weight retention one year after
pregnancy. Gestational diabetes and type 2 diabetes have
the same risk factors, and overweight and weight retention
after index pregnancy also seems to be important predictive
factors for impaired postpartum glucose tolerance.
Hunt has identiﬁed in a prospective cohort study of 707
womenseveralfactorsassociatedwithpostpartumscreening:
fewer children, lower fasting blood glucose levels at GDM
diagnosis, and no insulin treatment in pregnancy [14]. Thus
the women who returned for postpartum glucose screening
had less severe GDM than women who failed to return.
The same tendency was observed also in the current study:
over half (58% 33/57) of women with GDM and (57%
12/21) of women with insulin therapy did not attend for
testing. In an observational German study Schaefer-Graf
examined the association between an abnormal postpartum
OGTT and four risk factors: body mass index ≥30kg/m2,
gestational age at diagnosis <24 weeks, 1h antenatal glucose
value >11.1mmol/Landinsulintherapy.Womenwithtwoor
more risk factors had a high risk for an abnormal ppOGTT,
and 86% of postpartum diabetes was diagnosed within this
group [13].
Even though clinicians are aware that women with GDM
are at high risk of developing type 2 diabetes they do not
routinely screen patients. Providers identiﬁed poor commu-
nication between primary care providers and obstetric and
gynecology care providers as a major barrier to screening
[15]. The current study and the other reminding system
studies [7, 16, 17] shows that we have other barriers as
well. Feelings of emotional stress due to adjusting to a baby
and the fear of receiving a diagnosis of diabetes at the visit
were identiﬁed as key barriers in a small interview study
of 22 women [16]. Child care availability and desire for
checkup were among the key facilitators to screening. The
fear of receiving a diagnosis of diabetes may have explained
in the current study why overweight, multiparous and less
educated women frequently did not attend. This may also be
a reﬂection of a “healthy cohort” eﬀect, in which individuals
who are more health-conscious are more likely to seek
treatment or followup. On the other hand guidance during
pregnancy in the intervention group seems to increase the
likelihood for postpartum testing.
One of the strengths of this study is that it was performed
in a community-based setting in a rural area. This is the
ﬁrst study where the women with risk factors for GDM were
called for postpartum glucose testing. The limitation of this
study is the small number of women. The Electrical Medical
Record (EMR) covers now the study area and improves
the possibilities for expanding the system of reminding
by telephone. Timing the testing six months after delivery
when breastfeeding is ﬁnished and child care organized may
remove barriers.
5. Conclusion
We should improve the communication between primary
care providers and obstetrics and gynecology care providers
and endocrinologists and develop a reminding system for
primary care. A lifestyle intervention during pregnancy and
the knowledge that diabetes can be prevented may encourage
the women to participate in postpartum testing.6 International Journal of Endocrinology
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